News 03 May 2018 UICC and Pfizer announce four SPARC awardees selected to take their projects to the next level The University of Nigeria Teaching Hospital, FEMAMA and Instituto Oncoguia from Brazil, and Fundación Cima in Mexico, will receive a total amount of USD 20,000 to continue addressing the needs of metastatic breast cancer patients Header Paragraph The Union for International Cancer Control (UICC) and Pfizer Oncology are proud to announce the names of the four cancer organisations selected to receive additional funding for their SPARC projects, addressing the needs of metastatic breast cancer (MBC) patients. This funding was committed by Pfizer Oncology in 2017 as part of the second phase of SPARC. The organisations are: University of Nigeria Teaching Hospital in Enugu (Nigeria), with their project “UNTH – Breast Cancer Support Group” FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama) in Porto Alegre (Brazil), with their project “Cycle of Debates on Breast Canver for Congressmen” Asociación Mexicana contra el cancer de Mama AC (Fundación Cima) in Mexico DF (Mexico), with their project “Creating Spaces for Women with MBC user experience audit” Instituto Oncoguia in São Paulo (Brazil), with their project “Living with Metastatic Breast Cancer” These projects were selected by a panel of experts on the basis of excellence, and aim to improve the quality of life of MBC patients in their own settings through the development of a patient navigation system in Nigeria, running an advocacy campaign for lawmakers in Brazil, conducting a study on patients needs in Brazil, and strengthening patients care through an online platform for patients in Mexico. "The top-up grant will allow the birth of the first MBC horizontal community, targeting its very specific needs, as well as a source for open data analysis" said Alejandra de Cima, founder and president of Fundación Cima. Indeed, these four top-up awardees will be able to continue their projects in parallel to the 20 organisations from 19 countries granted with a SPARC award in 2017. The Seeding Progress and Resources for the Cancer Community (SPARC) Metastatic Breast Cancer Challenge grants, is a first-of-its-kind initiative aimed at empowering advocacy groups, hospital networks, support groups and other organisations worldwide as they initiate projects to close the gap in information, support, awareness, and policy between metastatic breast cancer and early breast cancer, as well as helping to reduce the number of women diagnosed at the metastatic stage of breast cancer. Tags SPARC Metastatic Breast Cancer challenge Pfizer Breast Cancer Last update Friday 24 March 2023 Share this page